Related Experiment Video
Updated: May 21, 2026
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Identification of novel target proteins in sebaceous gland carcinoma
Boban M Erovic1, Ayman Al Habeeb, Luke Harris
1Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Canada.
Background:
The aim of this study was to identify new target proteins in sebaceous gland carcinoma.
Methods:
A tissue microarray containing 115 core biopsies was constructed and stained for proteins involved in carcinogenesis, angiogenesis, inflammation, and cell-to-cell contact. Two investigators independently determined protein expression of all antibodies.
Results:
Vascular endothelial growth factor receptor 2 (VEGFR-2), platelet-derived growth factor receptor alpha and beta (PDGFR-α/-β), epidermal growth factor receptor (EGFR), cyclooxygenase 1 and 2 (Cox-1/-2), myeloid cell leukemia sequence 1 (Mcl-1), matrix metalloproteinase 1 (MMP-1), CD9, Bmi-1, 14-3-3σ, glutathione S-transferase pi (Gstπ), and members of the sonic hedgehog (SHH), AKT, and WNT pathways were significantly overexpressed in sebaceous gland carcinomas.
Conclusions:
We have demonstrated for the first time that proteins related to angiogenesis, inflammation, and cell proliferation are overexpressed in sebaceous gland carcinomas. These proteins may hold promise as novel therapeutic targets for the treatment of sebaceous gland carcinoma.
Insights
Sebaceous gland carcinomas overexpress proteins involved in angiogenesis, inflammation, and cell proliferation. These findings identify potential new therapeutic targets for this rare cancer.
Area of Science:
- Oncology
- Molecular Biology
- Dermatopathology
Background:
- Sebaceous gland carcinoma (SGC) is a rare malignant neoplasm.
- Identifying molecular targets is crucial for effective treatment strategies.
Purpose of the Study:
- To identify novel protein targets in sebaceous gland carcinoma.
- To investigate proteins associated with carcinogenesis, angiogenesis, inflammation, and cell-to-cell contact.
Main Methods:
- Construction of a tissue microarray with 115 SGC core biopsies.
- Immunohistochemical staining for key proteins.
- Independent assessment of protein expression by two investigators.
Main Results:
- Significant overexpression of VEGFR-2, PDGFR-α/-β, EGFR, Cox-1/-2, Mcl-1, MMP-1, CD9, Bmi-1, 14-3-3σ, Gstπ.
- Overexpression of proteins within the SHH, AKT, and WNT pathways.
- Identification of proteins linked to angiogenesis, inflammation, and cell proliferation.
Conclusions:
- Proteins regulating angiogenesis, inflammation, and cell proliferation are significantly overexpressed in SGC.
- These overexpressed proteins represent promising novel therapeutic targets for SGC treatment.
